FDA Inspection 1324334 — Biomat USA Inc
The FDA completed an inspection of Biomat USA Inc on June 5, 2026 in Cape Girardeau, MO. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 5, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Cape Girardeau, MO (United States)